|
Real-time
OTC Markets
15:50:39 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0785 USD | +3.29% |
|
+23.91% | -16.45% |
| 09-17 | MariMed Opens Thrive Dispensary Columbus as Part of Strategic Expansion | CI |
| 08-13 | MariMed Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 23.78M 21.2M 19.64M 17.85M 33.5M 2.25B 34.05M 236M 92.61M 1.18B 89.22M 87.35M 3.77B | P/E 2026 * |
-1.48x | P/E 2027 * | -1.97x |
|---|---|---|---|---|---|
| Enterprise Value | -49.74M -44.34M -41.07M -37.35M -70.08M -4.72B -71.23M -493M -194M -2.46B -187M -183M -7.88B | EV / Sales 2026 * |
-0.31x | EV / Sales 2027 * | -0.3x |
| Free-Float |
85.41% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: MariMed Inc.
| 1 day | +3.29% | ||
| 1 week | +23.91% | ||
| Current month | +12.14% | ||
| 1 month | +7.39% | ||
| 3 months | +19.30% | ||
| 6 months | +15.44% | ||
| Current year | -16.45% |
| 1 week | 0.06 |  | 0.08 |
| 1 month | 0.06 | | 0.08 |
| Current year | 0.06 | | 0.1 |
| 1 year | 0.06 | | 0.16 |
| 3 years | 0.06 | | 0.41 |
| 5 years | 0.06 | | 0.98 |
| 10 years | 0.06 | | 5.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Levine
CEO | Chief Executive Officer | 61 | 2022-12-13 |
Mario Pinho
DFI | Director of Finance/CFO | 58 | 2024-08-08 |
Jay O’Malley
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Gildea
CHM | Chairman | 74 | 2023-02-27 |
Jon Levine
BRD | Director/Board Member | 61 | 2015-12-31 |
David Allen
BRD | Director/Board Member | 71 | 2019-06-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/15/26 | Exercice | Chief Financial Officer | 87,800 | 0.0217% | ||
| 10/15/26 | Exercice | Executive/Senior Manager | 75,255 | 0.0186% | ||
| 10/15/26 | Exercice | Chief Operating Officer | 97,834 | 0.0242% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.29% | +23.91% | -48.59% | -80.22% | 23.78M | |
| +2.17% | +6.87% | -36.53% | +3.94% | 15.67B | |
| +16.62% | +3.43% | +12.06% | -17.36% | 7.07B | |
| +0.66% | +4.62% | -10.91% | +6.65% | 6.34B | |
| +0.77% | +3.55% | -11.51% | -1.44% | 6.34B | |
| +1.52% | +5.07% | -49.24% | -35.52% | 6.19B | |
| +1.16% | +5.49% | +2.71% | -8.25% | 4.54B | |
| -1.25% | +12.01% | -34.35% | -2.21% | 3.41B | |
| +0.02% | +1.05% | -14.02% | -8.96% | 3.24B | |
| +2.47% | +1.65% | +8.97% | -19.16% | 3.17B | |
| Average | +2.74% | +2.84% | -18.14% | -16.25% | 5.6B | |
| Weighted average by Cap. | +3.19% | +3.56% | -18.88% | -6.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 162M 145M 134M 122M 229M 15.4B 233M 1.61B 632M 8.05B 609M 597M 25.73B | 168M 150M 139M 126M 236M 15.91B 240M 1.66B 654M 8.31B 630M 616M 26.58B |
| Net income | -14.96M -13.33M -12.35M -11.23M -21.07M -1.42B -21.42M -148M -58.26M -741M -56.12M -54.95M -2.37B | -10.79M -9.62M -8.91M -8.1M -15.2M -1.02B -15.45M -107M -42.01M -535M -40.47M -39.62M -1.71B |
| Net Debt | -73.52M -65.54M -60.71M -55.2M -104M -6.97B -105M -728M -286M -3.64B -276M -270M -11.65B | -73.7M -65.69M -60.85M -55.33M -104M -6.99B -106M -730M -287M -3.65B -276M -271M -11.67B |
Employees
866
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | US$0.0590 | +3.87% | 253,397 |
| 26-10-15 | US$0.0568 | -5.33% | 785,674 |
| 26-10-14 | US$0.0600 | +1.69% | 351,434 |
| 26-10-13 | US$0.0590 | -5.90% | 1,154,512 |
| 26-10-12 | US$0.0627 | -1.03% | 617,667 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0590
Average target price
-
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRMD Stock
Select your edition
All financial news and data tailored to specific country editions
